Advanced Oncotherapy shares fall as testing progresses
24th Aug 2015 12:12
(ShareCast News) - Advanced Oncotherapy said two of its modules were ready for high power testing. The AIM listed proton therapy cancer treatment developer's shares fell by 3.33% to 7.25p by 1208 BST. Two of its Coupled Cavity Linac modules are now ready for high-power testing at the company's fac
Read moreAdvanced Oncotherapy's China partner signs framework deal
20th Aug 2015 10:36
(ShareCast News) - Advanced Oncotherapy said its partner in the Chinese market, Sinophi Healthcare, recently signed a framework agreement with China-Japan Union Hospital of Jilin University regarding a proton therapy centre. The company, which develops next-generation proton therapy systems for canc
Read moreAdvanced Oncotherapy's maiden losses widen depite good progress in LIGHT therapy system
3rd Jun 2015 08:23
Advanced Oncotherapy (AVO), developer of proton therapy systems for cancer treatment, saw its full-year losses increase despite a good progress in its Linac Image Guided Hadron Technology (LIGHT) therapy system. The group's revenues increased 54% to £106,378 from £68,916, but losses before tax jumpe
Read moreAdvanced Oncotherapy sells LIGHT therapy system to Sinophi for $40m
25th Mar 2015 11:49
Shares in Advanced Oncotherapy (AVO) jumped 55% after it announced Sinophi Healthcare will buy its LIGHT proton therapy system for $40m to be used in a hospital in China. AVO said the purchase of the Linac Image Guided Hadron Technology (LIGHT), a particle therapy systems machine, follows a number o
Read moreAdvanced Oncotherapy teams up with Toshiba
14th Aug 2014 11:37
Advanced Oncotheraphy has landed a five-year deal with Toshiba Electron Tubes & Devices to launch the firm's Light proton therapy machine. Under the agreement, Toshiba will supply Klystron, a wave-based particle accelerator component for Advanced Oncotherapy's Light machine, which uses proton-radia
Read moreAdmiral CFO sells shares awarded under group scheme
23rd Apr 2014 15:57
Kevin Chidwick, the Chief Financial Officer of FTSE 100 insurance giant Admiral Group, has traded in 37,500 of the 50,000 shares he was awarded under the group's discretionary free share scheme. Chidwick disposed of the shares at 1,350p each, generating proceeds of £506,250. His deputy, Geraint
Read moreAdvanced Oncotherapy appoints COO
22nd Nov 2013 07:44
Advanced Oncotherapy has officially appointed Sanjeev Pandya as Chief Operating Officer (COO) and as an Executive Director. Pandya had been acting as COO but has now been taken on permanently for the role with immediate effect. The 45-year-old, who has practised as an orthopaedic surgeon in the N
Read moreAdvanced Oncotherapy CEO makes triple purchase
26th Apr 2013 15:09
The Chief Executive of Advanced Oncotherapy, a provider of new technology for innovative and patient-focused cancer treatments, has this week purchased three lots of shares in the group, taking his stake to just under 69.4m shares. On Thursday Sinclair purchased one round of 8.075m shares at 1.59p
Read moreSpectris director buys 3,000 shares
25th Apr 2013 16:23
Martha Wyrsch, a Non-Executive Director of Spectris, the FTSE 250 instrumentation and controls company, has purchased her first set of shares in the company. Wyrsch, who took up the role in June last year, acquired 3,000 shares at 2,029.00p each for a total value of £60,870. The transaction was m
Read moreAdvanced Oncotherapy in talks to buy company with new cancer treatment technology
18th Feb 2013 10:39
Advanced Oncotherapy has signed a heads of terms to acquire an undisclosed company that has developed state of the art technology for treating cancerous tumours. The technology uses proton beam therapy (PBT), a form of radiation treatment for cancers which avoids harm to critical organs and tissues
Read more